Table of Contents Table of Contents
Previous Page  434 / 1416 Next Page
Information
Show Menu
Previous Page 434 / 1416 Next Page
Page Background

‹#›

Rationale for proton therapy in combined

modality therapy for NSCLC: reduced toxicity